Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis

Neuropsychopharmacology

Volumn 41, Issue 1, 2016, Pages 103-125

  Daniel, Sarah E ^a   Rainnie, Donald G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMPA RECEPTOR; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DOPAMINE; MESSENGER RNA; NORADRENALIN; SEROTONIN;

ANTERIOR COMMISSURE; BRAIN NERVE CELL; EXCITATORY POSTSYNAPTIC POTENTIAL; GLUTAMATERGIC SYNAPSE; HUMAN; IMMUNOHISTOCHEMISTRY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; STRESS; STRIA TERMINALIS; VENTRAL TEGMENTUM; ANIMAL; MENTAL STRESS; METABOLISM; NERVE CELL NETWORK; PATHOLOGY; PHYSIOLOGY; SEPTUM NUCLEUS;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; HUMANS; NERVE NET; NEURONAL PLASTICITY; NOREPINEPHRINE; SEPTAL NUCLEI; SEROTONIN; STRESS, PSYCHOLOGICAL;

EID: 84949548308     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.178     Document Type: Review

References (180)

1. Abrams JK, Johnson PL, Hay-Schmidt A, Mikkelsen JD, Shekhar A, Lowry CA (2005). Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 133: 983-997.
2. Albert PR, Vahid-Ansari F, Luckhart C (2014). Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5- HT1A receptor expression. Front Behav Neurosci 8: 199.
3. Alheid GF, Heimer L (1988). New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 27: 1-39.
4. Alves FHF, Crestani CC, Gomes FV, Guimarães FS, Correa FMA, Resstel LBM (2010). Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors. Pharmacol Res 62: 228-236.
5. Amat J, Baratta MV, Paul ED, Bland ST, Watkins LR, Maier SF (2005). Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci 8: 365-371.
6. Amat J, Tamblyn JP, Bland ST, Amat P, Foster AC, Watkins LR et al (2004). Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neurosci 129: 509-519.
7. Aston-Jones G, Delfs JM, Druhan J, Zhu Y (1999). The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann NY Acad Sci 877: 486-498.
8. Avery SN, Clauss JA, Winder DG, Woodward N, Heckers S, Blackford JU (2014). BNST neurocircuitry in humans. Neuroimage 91: 311-323.
9. Bale TL, Vale WW (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525-557.
10. Banihashemi L, Rinaman L (2006). Noradrenergic inputs to the bed nucleus of the stria terminalis and paraventricular nucleus of the hypothalamus underlie hypothalamic-pituitary-adrenal axis but not hypophagic or conditioned avoidance responses to systemic yohimbine. J Neurosci 26: 11442-11453.
11. Bota M, Sporns O, Swanson LW (2012). Neuroinformatics analysis of molecular expression patterns and neuron populations in gray matter regions: the rat BST as a rich exemplar. Brain Res 1450: 174-193.
12. Bowers LK, Swisher CB, Behbehani MM (2003). Membrane and synaptic effects of corticotropin-releasing factor on periaqueductal gray neurons of the rat. Brain Res 981: 52-57.
13. Brischoux F, Chakraborty S, Brierley DI, Ungless MA (2009). Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc Natl Acad Sci USA 106: 4894-4899.
14. Budygin EA, Park J, Bass CE, Grinevich VP, Bonin KD, Wightman RM (2012). Aversive stimulus differentially triggers subsecond dopamine release in reward regions. Neuroscience 201: 331-337.
15. Burghardt NS, Bauer EP (2013). Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits. Neuroscience 247: 253-272.
16. Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE (2004). The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55: 1171-1178.
17. Carboni E, Silvagni A, Rolando MT, Di Chiara G (2000). Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J Neurosci 20: RC102.
18. Cecchi M, Capriles N, Watson SJ, Akil H (2007). Beta1 adrenergic receptors in the bed nucleus of stria terminalis mediate differential responses to opiate withdrawal. Neuropsychopharmacology 32: 589-599.
19. Cecchi M, Khoshbouei H, Javors M, Morilak DA (2002). Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience 112: 13-21.
20. Choi DC, Furay AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, Herman JP (2007). Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J Neurosci 27: 2025-2034.
21. Commons KG, Connolley KR, Valentino RJ (2003). A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 28: 206-215.
22. Conrad KL, Louderback KM, Gessner CP, Winder DG (2011). Stress-induced alterations in anxiety-like behavior and adaptations in plasticity in the bed nucleus of the stria terminalis. Physiol Behav 104: 248-256.
23. Crestani CC, Alves FHF, Gomes FV, Resstel LB, Correa FM, Herman JP (2013). Mechanisms in the bed nucleus of the stria terminalis involved in control of autonomic and neuroendocrine functions: a review. Curr Neuropharmacol 11: 141-159.
24. Crestani CC, Alves FH, Resstel LB, Corrêa FM (2006). The bed nucleus of the stria terminalis modulates baroreflex in rats. Neuroreport 17: 1531-1535.
25. Crestani CC, Alves FHF, Tavares RF, Corrêa FMA (2009). Role of the bed nucleus of the stria terminalis in the cardiovascular responses to acute restraint stress in rats. Stress 12: 268-278.
26. Csáki Á, Kocsis K, Halász B, Kiss J (2000). Localization of glutamatergic/aspartatergic neurons projecting to the hypothalamic paraventricular nucleus studied by retrograde transport of [3H]d-aspartate autoradiography. Neuroscience 101: 637-655.
27. Cummings S, Elde R, Ells J, Lindall A (1983). Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 3: 1355-1368.
28. Dabrowska J, Hazra R, Ahern TH, Guo J-D, McDonald AJ, Mascagni F et al (2011). Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: implications for balancing stress and affect. Psychoneuroendocrinology 36: 1312-1326.
29. Dabrowska J, Hazra R, Guo J-D, Dewitt S, Rainnie DG (2013a). Central CRF neurons are not created equal: phenotypic differences in CRF-containing neurons of the rat paraventricular hypothalamus and the bed nucleus of the stria terminalis. Front Neurosci 7: 156.
30. Dabrowska J, Hazra R, Guo J-D, Li CC, DeWitt S, Xu J et al (2013b). Striatalenriched protein tyrosine phosphatase-STEPs toward understanding chronic stress-induced activation of corticotrophin releasing factor neurons in the rat bed nucleus of the stria terminalis. Biol Psychiatry 74: 817-826.
31. Dabrowska J, Rainnie DG (2014). Targeting corticotropin releasing factor (CRF) projections from the bed nucleus of the stria terminalis (BNST) using cell-type specific neuronal tracing studies in mice and rats. Neuropsychopharmacology 39: S315-S316.
32. Davis M, Walker DL (2014). Role of bed nucleus of the stria terminalis and amygdala AMPA receptors in the development and expression of context conditioning and sensitization of startle by prior shock. Brain Struct Funct 219: 1969-1982.
33. Day HEW, Curran EJ, Watson SJ, Akil H (1999). Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta. J Comp Neurol 413: 113-128.
34. Day HEW, Masini CV, Campeau S (2004). The pattern of brain c-fos mRNA induced by a component of fox odor, 2,5-dihydro-2,4,5-trimethylthiazoline (TMT), in rats, suggests both systemic and processive stress characteristics. Brain Res 1025: 139-151.
35. Day HEW, Vittoz NM, Oates MM, Badiani A, Watson SJ, Robinson TE et al (2002). A 6-hydroxydopamine lesion of the mesostriatal dopamine system decreases the expression of corticotropin releasing hormone and neurotensin mRNAs in the amygdala and bed nucleus of the stria terminalis. Brain Res 945: 151-159.
36. Deyama S, Katayama T, Ohno A, Nakagawa T, Kaneko S, Yamaguchi T et al (2008). Activation of the beta-adrenoceptor-protein kinase A signaling pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain in rats. J Neurosci 28: 7728-7736.
37. Dong HW, Petrovich GD, Swanson LW (2000). Organization of projections from the juxtacapsular nucleus of the BST: a PHAL study in the rat. Brain Res 859: 1-14.
38. Dong HW, Petrovich GD, Swanson LW (2001a). Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev 38: 192-246.
39. Dong HW, Petrovich GD, Watts AG, Swanson LW (2001b). Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol 436: 430-455.
40. Dong HW, Swanson LW (2004). Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis. J Comp Neurol 468: 277-298.
41. Dumont EC, Williams JT (2004). Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci 24: 8198-8204.
42. Duvarci S, Bauer EP, Pare D (2009). The bed nucleus of the stria terminalis mediates inter-individual variations in anxiety and fear. J Neurosci 29: 10357-10361.
43. Egli RE, Kash TL, Choo K, Savchenko V, Matthews RT, Blakely RD et al (2004). Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology 30: 657-668.
44. Eiler WJA, Seyoum R, Foster KL, Mailey C, June HL (2003). D1 dopamine receptor regulates alcohol-motivated behaviors in the bed nucleus of the stria terminalis in alcohol-preferring (P) rats. Synapse 48: 45-56.
45. Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J (2000). Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23: 138-150.
46. Erb S, Salmaso N, Salmaso N, Rodaros D, Stewart J (2001). A role for the CRFcontaining pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology 158: 360-365.
47. Erb S, Stewart J (1999). A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19: RC35.
48. Fendt M, Siegl S, Steiniger-Brach B (2005). Noradrenaline transmission within the ventral bed nucleus of the stria terminalis is critical for fear behavior induced by trimethylthiazoline, a component of fox odor. J Neurosci 25: 5998-6004.
49. Flavin SA, Matthews RT, Wang Q, Muly EC, Winder DG (2014). α(2A)-adrenergic receptors filter parabrachial inputs to the bed nucleus of the stria terminalis. J Neurosci 34: 9319-9331.
50. Forray MI, Bustos G, Gysling K (1999). Noradrenaline inhibits glutamate release in the rat bed nucleus of the stria terminalis: in vivo microdialysis studies. J Neurosci Res 55: 311-320.
51. Forray MI, Gysling K, Andrés ME, Bustos G, Araneda S (2000). Medullary noradrenergic neurons projecting to the bed nucleus of the stria terminalis express mRNA for the NMDA-NR1 receptor. Brain Res Bull 52: 163-169.
52. Fox AS, Shelton SE, Oakes TR, Converse AK, Davidson RJ, Kalin NH (2010). Orbitofrontal cortex lesions alter anxiety-related activity in the primate bed nucleus of stria terminalis. J Neurosci 30: 7023-7027.
53. Fox JH, Lowry CA (2013). Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior. Front Neurosci 7: 169.
54. Francesconi W, Berton F, Repunte-Canonigo V, Hagihara K, Thurbon D, Lekic D et al (2009). Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. J Neurosci 29: 5389-5401.
55. Freedman LJ, Cassell MD (1994). Distribution of dopaminergic fibers in the central division of the extended amygdala of the rat. Brain Res 633: 243-252.
56. Funk D, Li Z, Lê AD (2006). Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: relationship to the reinstatement of alcohol seeking. Neuroscience 138: 235-243.
57. Gardner KL, Thrivikraman KV, Lightman SL, Plotsky PM, Lowry CA (2005). Early life experience alters behavior during social defeat: focus on serotonergic systems. Neuroscience 136: 181-191.
58. Georges F, Aston-Jones G (2001). Potent regulation of midbrain dopamine neurons by the bed nucleus of the stria terminalis. J Neurosci 21: RC160.
59. Georges F, Aston-Jones G (2002). Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 22: 5173-5187.
60. Glangetas C, Girard D, Groc L, Marsicano G, Chaouloff F, Georges F (2013). Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis. J Neurosci 33: 19657-19663.
61. Goebel-Goody SM, Baum M, Paspalas CD, Fernandez SM, Carty NC, Kurup P (2012). Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders. Pharmacol Rev 64: 65-87.
62. Gomes FV, Alves FHF, Guimarães FS, Correa FMA, Resstel LBM, Crestani CC (2013). Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptor. Eur Neuropsychopharmacol 23: 1096-1104.
63. Gomes FV, Reis DG, Alves FHF, Correa FM, Guimaraes FS, Resstel LB (2012). Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors. J Psychopharmacol 26: 104-113.
64. Gomes FV, Resstel LBM, Guimarães FS (2011). The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors. Psychopharmacology 213: 465-473.
65. Grahn RE, Will MJ, Hammack SE, Maswood S, McQueen MB, Watkins LR et al (1999). Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor. Brain Research 826: 35-43.
66. Gray TS, Magnuson DJ (1992). Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13: 451-460.
67. Grillon C, Levenson J, Pine DS (2007). A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology 32: 225-231.
68. Guo J-D, Hammack SE, Hazra R, Levita L, Rainnie DG (2009). Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes. Neuroscience 164: 1776-1793.
69. Guo J-D, Rainnie DG (2010). Presynaptic 5-HT(1B) receptor-mediated serotonergic inhibition of glutamate transmission in the bed nucleus of the stria terminalis. Neuroscience 165: 1390-1401.
70. Hale MW, Stamper CE, Staub DR, Lowry CA (2010). Urocortin 2 increases c-Fos expression in serotonergic neurons projecting to the ventricular/periventricular system. Exp Neurol 224: 271-281.
71. Hammack SE, Guo J-D, Hazra R, Dabrowska J, Myers KM, Rainnie DG (2009). The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety. Prog in Neuropsychopharmacol Biol Psychiatry 33: 1309-1320.
72. Hammack SE, Mania I, Rainnie DG (2007). Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol 98: 638-656.
73. Hammack SE, Richey KJ, Schmid MJ, LoPresti ML, Watkins LR, Maier SF (2002). The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. J Neurosci 22: 1020-1026.
74. Hammack SE, Schmid MJ, LoPresti ML, Der-Avakian A, Pellymounter MA, Foster AC et al (2003). Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J Neurosci 23: 1019-1025.
75. Hasue RH, Shammah-Lagnado SJ (2002). Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat. J Comp Neurol 454: 15-33.
76. Haubensak W, Kunwar PS, Cai H, Ciocchi S, Wall NR, Ponnusamy R et al (2010). Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 468: 270-276.
77. Hazra R, Guo J-D, Dabrowska J, Rainnie DG (2012). Differential distribution of serotonin receptor subtypes in BNST(ALG) neurons: modulation by unpredictable shock stress. Neuroscience 225: 9-21.
78. Hazra R, Guo J-D, Ryan SJ, Jasnow AM, Dabrowska J, Rainnie DG (2011). A transcriptomic analysis of type I-III neurons in the bed nucleus of the stria terminalis. Mol Cell Neurosci 46: 699-709.
79. Hedlund PB (2009). The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology 206: 345-354.
80. Heisler LK, Zhou L, Bajwa P, Hsu J, Tecott LH (2007). Serotonin 5-HT(2C) receptors regulate anxiety-like behavior. Genes Brain Behav 6: 491-496.
81. Hott SC, Gomes FV, Fabri DRS, Reis DG, Crestani CC, Correa FMA et al (2012). Both α1- and β1-adrenoceptors in the bed nucleus of the stria terminalis are involved in the expression of conditioned contextual fear. Br J Pharmacol 167: 207-221.
82. Hubert GW, Muly EC (2014). Distribution of AMPA receptor subunit glur1 in the bed nucleus of the stria terminalis and effect of stress. Synapse 68: 194-201.
83. Ide S, Hara T, Ohno A, Tamano R, Koseki K, Naka T et al (2013). Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats. J Neurosci 33: 5881-5894.
84. Imaki T, Nahan JL, Rivier C, Sawchenko PE, Vale W (1991). Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J Neurosci 11: 585-599.
85. Jalabert M, Aston-Jones G, Herzog E, Manzoni O, Georges F (2009). Role of the bed nucleus of the stria terminalis in the control of ventral tegmental area dopamine neurons. Prog Neuropsychopharmacol Biol Psychiatry 33: 1336-1346.
86. Janitzky K, D Hanis W, Kröber A, Schwegler H (2014). TMT predator odor activated neural circuit in C57BL/6J mice indicates TMT-stress as a suitable model for uncontrollable intense stress. Brain Res 1599: 1-8.
87. Jasnow AM, Davis M, Huhman KL (2004). Involvement of central amygdalar and bed nucleus of the stria terminalis corticotropin-releasing factor in behavioral responses to social defeat. Behav Neurosci 118: 1052-1061.
88. Jennings JH, Sparta DR, Stamatakis AM, Ung RL, Pleil KE, Kash TL et al (2013). Distinct extended amygdala circuits for divergent motivational states. Nature 496: 224-228.
89. Ju G, Swanson LW, Simerly RB (1989). Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: II. Chemoarchitecture. J Comp Neurol 280: 603-621.
90. Kalin NH, Shelton SE, Fox AS, Oakes TR, Davidson RJ (2005). Brain regions associated with the expression and contextual regulation of anxiety in primates. Biol Psychiatry 58: 796-804.
91. Kash TL, Nobis WP, Matthews RT, Winder DG (2008). Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J Neurosci 28: 13856-13865.
92. Kash TL, Winder DG (2006). Neuropeptide Y and corticotropin-releasing factor bidirectionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51: 1013-1022.
93. Kent JM, Coplan JD, Gorman JM (1998). Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry 44: 812-824.
94. Kim S-J, Park S-H, Choi S-H, Moon B-H, Lee K-J, Kang SW et al (2006). Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats. Neuropharmacology 50: 824-833.
95. Kim S-Y, Adhikari A, Lee SY, Marshel JH, Kim CK, Mallory CS et al (2013). Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature 496: 219-223.
96. Kimura A, Stevenson PL, Carter RN, MacColl G, French KL, Simons JP et al (2009). Overexpression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity. Eur J Neurosci 30: 299-306.
97. Kirby LG, Rice KC, Valentino RJ (2000). Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22: 148-162.
98. Koob GF (2010). The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res 1314: 3-14.
99. Kormos V, Gaszner B (2013). Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropeptides 47: 401-419.
100. Krawczyk M, Georges F, Sharma R, Mason X, Berthet A, Bézard E et al (2011a). Double-dissociation of the catecholaminergic modulation of synaptic transmission in the oval bed nucleus of the stria terminalis. J Neurophysiol 105: 145-153.
101. Krawczyk M, Sharma R, Mason X, Debacker J, Jones AA, Dumont EC (2011b). A switch in the neuromodulatory effects of dopamine in the oval bed nucleus of the stria terminalis associated with cocaine self-administration in rats. J Neurosci 31: 8928-8935.
102. Krüger O, Shiozawa T, Kreifelts B, Scheffler K, Ethofer T (2015). Three distinct fiber pathways of the bed nucleus of the stria terminalis to the amygdala and prefrontal cortex. Cortex 66: 60-68.
103. Kudo T, Uchigashima M, Miyazaki T, Konno K, Yamasaki M, Yanagawa Y et al (2012). Three types of neurochemical projection from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice. J Neurosci 32: 18035-18046.
104. Larriva-Sahd J (2006). Histological and cytological study of the bed nuclei of the stria terminalis in adult rat. II. Oval nucleus: extrinsic inputs, cell types, neuropil, and neuronal modules. J Comp Neurol 497: 772-807.
105. Lee Y, Davis M (1997). Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci 17: 6434-6446.
106. Leri F, Flores J, Rodaros D, Stewart J (2002a). Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22: 5713-5718.
107. Leri F, Flores J, Rodaros D, Stewart J (2002b). Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22: 5713-5718.
108. Levita L, Hammack SE, Mania I, Li XY, Davis M, Rainnie DG (2004). 5-hydroxytryptamine1A-like receptor activation in the bed nucleus of the stria terminalis: electrophysiological and behavioral studies. Neuroscience 128: 583-596.
109. Liang KC, Chen HC, Chen DY (2001). Posttraining infusion of norepinephrine and corticotropin releasing factor into the bed nucleus of the stria terminalis enhanced retention in an inhibitory avoidance task. Chin J Physiol 44: 33-43.
110. Lowry CA (2002). Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol 14: 911-923.
111. Makino S, Gold PW, Schulkin J (1994). Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 657: 141-149.
112. Mansari, El M, Guiard BP, Chernoloz O, Ghanbari R, Katz N, Blier P (2010). Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. CNS Neurosci Ther 16: e1-17.
113. Mantsch JR, Vranjkovic O, Twining RC, Gasser PJ, McReynolds JR, Blacktop JM (2014). Neurobiological mechanisms that contribute to stress-related cocaine use. Neuropharmacology 76 Pt B: 383-394.
114. Marcinkiewcz CA, Dorrier CE, Lopez AJ, Kash TL (2015). Ethanol induced adaptations in 5-HT2c receptor signaling in the bed nucleus of the stria terminalis: implications for anxiety during ethanol withdrawal. Neuropharmacology 89: 157-167.
115. Martin EI, Ressler KJ, Jasnow AM, Dabrowska J, Hazra R, Rainnie DG et al (2010). A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor. Biol Psychiatry 67: 1212-1216.
116. Massi L, Elezgarai I, Puente N, Reguero L, Grandes P, Manzoni OJ, Georges F (2008). Cannabinoid receptors in the bed nucleus of the stria terminalis control cortical excitation of midbrain dopamine cells in vivo. J Neurosci 28: 10496-10508.
117. McDonald AJ, Shammah-Lagnado SJ, Shi C, Davis M (1999). Cortical afferents to the extended amygdala. Ann NY Acad Sci 877: 309-338.
118. McElligott ZA, Klug JR, Nobis WP, Patel S, Grueter BA, Kash TL et al (2010). Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress. Proc Natl Acad Sci USA 107: 2271-2276.
119. McElligott ZA, Winder DG (2007). α1-adrenergic receptor-induced heterosynaptic long-term depression in the bed nucleus of the stria terminalis is disrupted in mouse models of affective disorders. Neuropsychopharmacology 33: 2313-2323.
120. Meloni EG, Gerety LP, Knoll AT, Cohen BM, Carlezon WA (2006). Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat. J Neurosci 26: 3855-3863.
121. Mengod G, Villaró MT, Landwehrmeyer GB, Martinez-Mir MI, Niznik HB, Sunahara RK et al (1992). Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain. Neurochem Int 20: 33S-43S.
122. Michaeli A, Yaka R (2010). Dopamine inhibits GABA(A) currents in ventral tegmental area dopamine neurons via activation of presynaptic G-protein coupled inwardlyrectifying potassium channels. J Neurosci 165: 1159-1169.
123. Miczek KA, Nikulina E, Kream RM, Carter G, Espejo EF (1999). Behavioral sensitization to cocaine after a brief social defeat stress: c-fos expression in the PAG. Psychopharmacology 141: 225-234.
124. Mnie-Filali O, Faure C, Lambás-Señas L, Mansari El M, Belblidia H, Gondard E et al (2011). Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology 36: 1275-1288.
125. Nautiyal KM, Tanaka KF, Barr MM, Tritschler L, Le Dantec Y, David DJ et al (2015). Distinct circuits underlie the effects of 5-HT1B receptors on aggression and impulsivity. Neuron 86: 813-826.
126. Nakagawa T, Yamamoto R, Fujio M, Suzuki Y, Minami M, Satoh M et al (2005). Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience 134: 9-19.
127. Nobis WP, Kash TL, Silberman Y, Winder DG (2011). β-Adrenergic receptors enhance excitatory transmission in the bed nucleus of the stria terminalis through a corticotrophin-releasing factor receptor-dependent and cocaine-regulated mechanism. Biol Psychiatry 69: 1083-1090.
128. Oler JA, Fox AS, Shelton SE, Christian BT, Murali D, Oakes TR et al (2009). Serotonin transporter availability in the amygdala and bed nucleus of the stria terminalis predicts anxious temperament and brain glucose metabolic activity. J Neurosci 29: 9961-9966.
129. Onaka T, Yagi K (1998). Role of noradrenergic projections to the bed nucleus of the stria terminalis in neuroendocrine and behavioral responses to fear-related stimuli in rats. Brain Res 788: 287-293.
130. Park J, Bucher ES, Budygin EA, Wightman RM (2015). Norepinephrine and dopamine transmission in 2 limbic regions differentially respond to acute noxious stimulation. Pain 156: 318-327.
131. Park J, Bucher ES, Fontillas K, Owesson-White C, Ariansen JL, Carelli RM et al (2013). Opposing catecholamine changes in the bed nucleus of the stria terminalis during intracranial self-stimulation and its extinction. Biol Psychiatry 74: 69-76.
132. Park J, Kile BM, Wightman RM (2009). In vivo voltammetric monitoring of norepinephrine release in the rat ventral bed nucleus of the stria terminalis and anteroventral thalamic nucleus. Eur J Neurosci 30: 2121-2133.
133. Park J, Wheeler RA, Fontillas K, Keithley RB, Carelli RM, Wightman RM (2012). Catecholamines in the bed nucleus of the stria terminalis reciprocally respond to reward and aversion. Biol Psychiatry 71: 327-334.
134. Paul S, Olausson P, Venkitaramani DV, Ruchkina I, Moran TD, Tronson N et al (2007). The striatal-enriched protein tyrosine phosphatase gates long-term potentiation and fear memory in the lateral amygdala. Biol Psychiatry 61: 1049-1061.
135. Petit JM, Luppi PH, Peyron C, Rampon C, Jouvet M (1995). VIP-like immunoreactive projections from the dorsal raphe and caudal linear raphe nuclei to the bed nucleus of the stria terminalis demonstrated by a double immunohistochemical method in the rat. Neurosci Lett 193: 77-80.
136. Peyron C, Petit JM, Rampon C, Jouvet M, Luppi PH (1998). Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 82: 443-468.
137. Pêgo JM, Morgado P, Pinto LG, Cerqueira JJ, Almeida OFX, Sousa N (2008). Dissociation of the morphological correlates of stress-induced anxiety and fear. Eur J Neurosci 27: 1503-1516.
138. Phelix CF, Liposits Z, Paull WK (1992). Serotonin-CRF interaction in the bed nucleus of the stria terminalis: a light microscopic double-label immunocytochemical analysis. Brain Res Bull 28: 943-948.
139. Phelix CF, Liposits Z, Paull WK (1994). Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis. Brain Res Bull 33: 109-119.
140. Pleil KE, Rinker JA, Lowery-Gionta EG, Mazzone CM, McCall NM, Kendra AM et al (2015). NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking. Nat Neurosci 18: 545-552.
141. Radley JJ, Gosselink KL, Sawchenko PE (2009). A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. J Neurosci 29: 7330-7340.
142. Robinson OJ, Overstreet C, Allen PS, Pine DS, Grillon C (2012). Acute tryptophan depletion increases translational indices of anxiety but not fear: serotonergic modulation of the bed nucleus of the stria terminalis? Neuropsychopharmacology 37: 1963-1971.
143. Rodaros D, Caruana DA, Amir S, Stewart J (2007). Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neurosci 150: 8-13.
144. Rodríguez-Sierra OE, Turesson HK, Pare D (2013). Contrasting distribution of physiological cell types in different regions of the bed nucleus of the stria terminalis. J Neurophysiol 110: 2037-2049.
145. Sahuque LL, Kullberg EF, Mcgeehan AJ, Kinder JR, Hicks MP, Blanton MG et al (2006). Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology 186: 122-132.
146. Sakanaka M, Shibasaki T, Lederis K (1986). Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res 382: 213-238.
147. Saudou F, Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L et al (1994). Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265: 1875-1878.
148. Savasta M, Dubois A, Scatton B (1986). Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390. Brain Res 375: 291-301.
149. Sawchenko PE, Swanson LW (1985). Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed Proc 44: 221-227.
150. Scibilia RJ, Lachowicz JE, Kilts CD (1992). Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse 11: 146-154.
151. Shaham Y, Highfield D, Delfs J, Leung S, Stewart J (2000). Clonidine blocks stressinduced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci 12: 292-302.
152. Shalev U, Morales M, Hope B, Yap J, Shaham Y (2001). Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology 156: 98-107.
153. Shin J-W, Geerling JC, Loewy AD (2008). Inputs to the ventrolateral bed nucleus of the stria terminalis. J Comp Neurol 511: 628-657.
154. Silberman Y, Matthews RT, Winder DG (2013). A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis. J Neurosci 33: 950-960.
155. Sink KS, Davis M, Walker DL (2013). CGRP antagonist infused into the bed nucleus of the stria terminalis impairs the acquisition and expression of context but not discretely cued fear. Learn Mem 20: 730-739.
156. Somerville LH, Whalen PJ, Kelley WM (2010). Human bed nucleus of the stria terminalis indexes hypervigilant threat monitoring. Biol Psychiatry 68: 416-424.
157. Sparta DR, Jennings JH, Ung RL, Stuber GD (2013). Optogenetic strategies to investigate neural circuitry engaged by stress. Behav Brain Res 255: 19-25.
158. Staub DR, Spiga F, Lowry CA (2005). Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus. Brain Res 1044: 176-189.
159. Stokes PE, Holtz A (1997). Fluoxetine tenth anniversary update: the progress continues. Clin Ther 19: 1135-1250.
160. Straube T, Mentzel H-J, Miltner WHR (2007). Waiting for spiders: brain activation during anticipatory anxiety in spider phobics. Neuroimage 37: 1427-1436.
161. Sullivan GM, Apergis J, Bush DEA, Johnson LR, Hou M, Ledoux JE (2004). Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 128: 7-14.
162. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36: 165-186.
163. Swanson LW, Simmons DM (1989). Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J Comp Neurol 285: 413-435.
164. Tropea D, Capsoni S, Tongiorgi E, Giannotta S, Cattaneo A, Domenici L (2001). Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience. Eur J Neurosci 13: 709-721.
165. Turesson HK, Rodriguez-Sierra OE, Pare D (2013). Intrinsic connections in the anterior part of the bed nucleus of the stria terminalis. J Neurophysiol 109: 2438-2450.
166. Valjent E, Pages C, Herve D, Girault J-A, Caboche J (2004). Addictive and nonaddictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 19: 1826-1836.
167. Valjent E, Pascoli V, Pascoli V, Svenningsson P, Svenningsson P, Paul S et al (2005). Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci USA 102: 491-496.
168. Van Bockstaele EJ, Peoples J, Valentino RJ (1999). A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol Psychiatry 46: 1352-1363.
169. Vranjkovic O, Hang S, Baker DA, Mantsch JR (2012). β-adrenergic receptor mediation of stress-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: roles for β1 and β2 adrenergic receptors. J Pharmacol Exp Ther 342: 541-551.
170. Vyas A, Bernal S, Chattarji S (2003). Effects of chronic stress on dendritic arborization in the central and extended amygdala. Brain Res 965: 290-294.
171. Walker DL, Davis M (2008). Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct Funct 213: 29-42.
172. Walker DL, Miles LA, Davis M (2009). Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog Neuropsychopharmacol Biol Psychiatry 33: 1291-1308.
173. Walsh JJ, Han MH (2014). The heterogeneity of ventral tegmental area neurons: projection functions in a mood-related context. Neuroscience 282C: 101-108.
174. Walter A, Mai JK, Lanta L, Görcs T (1991). Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J Chem Neuroanat 4: 281-298.
175. Watts AG, Kelly AB, Sanchez-Watts G (1995). Neuropeptides and thirst: the temporal response of corticotropin-releasing hormone and neurotensin/neuromedin N gene expression in rat limbic forebrain neurons to drinking hypertonic saline. Behav Neurosci 109: 1146-1157.
176. Weller KL, Smith DA (1982). Afferent connections to the bed nucleus of the stria terminalis. Brain Res 232: 255-270.
177. Wilde MI, Benfield P (1995). Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 49: 411-439.
178. Yang C-H, Huang C-C, Hsu K-S (2012). A critical role for protein tyrosine phosphatase nonreceptor type 5 in determining individual susceptibility to develop stress-related cognitive and morphological changes. J Neurosci 32: 7550-7562.
179. Yassa MA, Hazlett RL, Stark CEL, Hoehn-Saric R (2012). Functional MRI of the amygdala and bed nucleus of the stria terminalis during conditions of uncertainty in generalized anxiety disorder. J Psychiatr Res 46: 1045-1052.
180. Zimmerman JM, Maren S (2011). The bed nucleus of the stria terminalis is required for the expression of contextual but not auditory freezing in rats with basolateral amygdala lesions. Neurobiol Learn Mem 95: 199-205.